Company / Current Liabilities
Citius Pharmaceuticals, Inc. Current Liabilities History
FY2011-FY2013 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$14.7K
FY2013
5-year range
$14.7K / $46.0K
FY2011-FY2013
Trend
-68.0%
vs FY2012
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $24,053 to $14,694 over the past 2 years.
Based on SEC 10-K filings.
$14,694 in FY2013.
Improved from $24,053 to $14,694 over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2013, current liabilities decreased 68.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2013 | $14.7K | -68.0% |
| FY2012 | $46.0K | +91.2% |
| FY2011 | $24.1K | - |
As of FY2013 · SEC 10-K · Updated Jun 22, 2026